Overview

Bioequivalence Study of Terbinafine Hydrochloride Tablets, 250 mg of Dr. Reddy's Under Fasting Conditions

Status:
Completed
Trial end date:
2002-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the rate and extent of absorption of terbinafine hydrochloride 250 mg tablets versus LamisilĀ® 250 mg tablets administered as 1 x 250 mg tablet under fasting conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Dr. Reddy's Laboratories Limited
Treatments:
Terbinafine